{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T00:55:09Z","timestamp":1648515309897},"reference-count":43,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2021,11,29]]},"DOI":"10.1536\/ihj.21-662","type":"journal-article","created":{"date-parts":[[2021,11,29]],"date-time":"2021-11-29T22:13:56Z","timestamp":1638224036000},"page":"1195-1198","source":"Crossref","is-referenced-by-count":0,"title":["Electrical Storm"],"prefix":"10.1536","volume":"62","author":[{"given":"Kunihiro","family":"Kani","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuhito","family":"Fujiu","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Al-Khatib SM, Stevenson WG, Ackerman MJ, <i>et al<\/i>. 2017 AHA\/ACC\/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: Executive summary: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Heart Rhythm 2018; 15: e190-252.","DOI":"10.1016\/j.hrthm.2017.10.035"},{"key":"2","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1093\/europace\/eux166","volume":"20","year":"2018","unstructured":"2. Guerra F, Palmisano P, Dell&apos;Era G, <i>et al<\/i>. Cardiac resynchronization therapy and electrical storm: results of the OBSERVational registry on long-term outcome of ICD patients (OBSERVO-ICD). Europace 2018; 20: 979-85.","journal-title":"Europace","ISSN":"http:\/\/id.crossref.org\/issn\/1099-5129","issn-type":"print"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Nedios S, Darma A, Stevanello C, <i>et al<\/i>. Electrical storm in patients with implantable cardioverter-defibrillator in the era of catheter ablation: Implications for better rhythm control. Heart Rhythm 2015; 12: 2419-25.","DOI":"10.1016\/j.hrthm.2015.07.034"},{"key":"4","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1161\/01.CIR.92.11.3255","volume":"92","year":"1995","unstructured":"4. Kowey PR, Levine JH, Herre JM, <i>et al<\/i>. Randomized, double-blind comparison of intravenous amiodarone and bretylium in the treatment of patients with recurrent, hemodynamically destabilizing ventricular tachycardia or fibrillation. The Intravenous Amiodarone Multicenter Investigators Group. Circulation 1995; 92: 3255-63.","journal-title":"Circulation","ISSN":"http:\/\/id.crossref.org\/issn\/0009-7322","issn-type":"print"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Watanabe M, Yokoshiki H, Noda T, <i>et al<\/i>. Electrical storm as an independent mortality risk in patients with preserved or moderately reduced left ventricular function: Results from a Japanese Nationwide Registry. Int Heart J 2021; 62: 1249-56.","DOI":"10.1536\/ihj.20-832"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Anderson ME. Calcium and stunning: when, from where, and what next?J Cardiovasc Electrophysiol 2002; 13: 1025-6.","DOI":"10.1046\/j.1540-8167.2002.01025.x"},{"key":"7","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1136\/hrt.79.6.560","volume":"79","year":"1998","unstructured":"7. Bode F, Wiegand U, Raasch W, <i>et al<\/i>. Differential effects of defibrillation on systemic and cardiac sympathetic activity. Heart 1998; 79: 560-7.","journal-title":"Heart","ISSN":"http:\/\/id.crossref.org\/issn\/1355-6037","issn-type":"print"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Maruyama M. Management of electrical storm: The mechanism matters. J Arrhythm 2014; 30: 242-9.","DOI":"10.1016\/j.joa.2014.03.012"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Verma A, Kilicaslan F, Marrouche NF, <i>et al<\/i>. Prevalence, predictors, and mortality significance of the causative arrhythmia in patients with electrical storm. J Cardiovasc Electrophysiol 2004; 15: 1265-70.","DOI":"10.1046\/j.1540-8167.2004.04352.x"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Maruyama M, Joung B, Tang L, <i>et al<\/i>. Diastolic intracellular calcium-membrane voltage coupling gain and postshock arrhythmias: role of purkinje fibers and triggered activity. Circ Res 2010; 106: 399-408.","DOI":"10.1161\/CIRCRESAHA.109.211292"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Nattel S, Dobrev D. The multidimensional role of calcium in atrial fibrillation pathophysiology: mechanistic insights and therapeutic opportunities. Eur Heart J 2012; 33: 1870-7.","DOI":"10.1093\/eurheartj\/ehs079"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Couchonnal LF, Anderson ME. The role of calmodulin kinase II in myocardial physiology and disease. Physiology (Bethesda) 2008; 23: 151-9.","DOI":"10.1152\/physiol.00043.2007"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Chua SK, Chang PC, Maruyama M, <i>et al<\/i>. Small-conductance calcium-activated potassium channel and recurrent ventricular fibrillation in failing rabbit ventricles. Circ Res 2011; 108: 971-9.","DOI":"10.1161\/CIRCRESAHA.110.238386"},{"key":"14","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.hrthm.2009.02.017","volume":"6","year":"2009","unstructured":"14. Ogawa M, Morita N, Tang L, <i>et al<\/i>. Mechanisms of recurrent ventricular fibrillation in a rabbit model of pacing-induced heart failure. Heart Rhythm 2009; 6: 784-92.","journal-title":"Heart Rhythm","ISSN":"http:\/\/id.crossref.org\/issn\/1547-5271","issn-type":"print"},{"key":"15","doi-asserted-by":"publisher","unstructured":"15. Yan GX, Joshi A, Guo D, <i>et al<\/i>. Phase 2 reentry as a trigger to initiate ventricular fibrillation during early acute myocardial ischemia. Circulation 2004; 110: 1036-41.","DOI":"10.1161\/01.CIR.0000140258.09964.19"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Schwartz PJ, Ackerman MJ, Antzelevitch C, <i>et al<\/i>. Inherited cardiac arrhythmias. Nat Rev Dis Primers 2020; 6: 58.","DOI":"10.1038\/s41572-020-0188-7"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Antzelevitch C, Oliva A. Amplification of spatial dispersion of repolarization underlies sudden cardiac death associated with catecholaminergic polymorphic VT, long QT, short QT and Brugada syndromes. J Intern Med 2006; 259: 48-58.","DOI":"10.1111\/j.1365-2796.2005.01587.x"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Lankipalli RS, Zhu T, Guo D, <i>et al<\/i>. Mechanisms underlying arrhythmogenesis in long QT syndrome. J Electrocardiol 2005; 38: 69-73.","DOI":"10.1016\/j.jelectrocard.2005.06.008"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Wallace E, Howard L, Liu M, <i>et al<\/i>. Long QT syndrome: Genetics and future perspective. Pediatr Cardiol 2019; 40: 1419-30.","DOI":"10.1007\/s00246-019-02151-x"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Brugada J, Campuzano O, Arbelo E, Present Status, of Brugada. Syndrome: JACC State-of-the-Art Review. J Am Coll Cardiol 2018; 72: 1046-59.","DOI":"10.1016\/j.jacc.2018.06.037"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Bueno-Orovio A, Cherry EM, Evans SJ, <i>et al<\/i>. Basis for the induction of tissue-level phase-2 reentry as a repolarization disorder in the Brugada syndrome. Biomed Res Int 2015; 2015: 197586.","DOI":"10.1155\/2015\/197586"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Talib AK, Nogami A. Catheter ablation for Brugada syndrome. Korean Circ J 2020; 50: 289-301.","DOI":"10.4070\/kcj.2019.0344"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Rizzo A, de Asmundis C, Brugada P, <i>et al<\/i>. Ablation for the treatment of Brugada syndrome: current status and future prospects. Expert Rev Med Devices 2020; 17: 123-30.","DOI":"10.1080\/17434440.2020.1719831"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Baltogiannis GG, Lysitsas DN, di Giovanni G, <i>et al<\/i>. CPVT: Arrhythmogenesis, therapeutic management, and future perspectives. A brief review of the literature. Front Cardiovasc Med 2019; 6: 92.","DOI":"10.3389\/fcvm.2019.00092"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. L Nguyen H, Vaseghi M. Sympathetic denervation for treatment of ventricular arrhythmias. J Atr Fibrillation 2020; 13: 2404.","DOI":"10.4022\/jafib.2404"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Vaseghi M, Barwad P, Malavassi Corrales FJ. Cardiac sympathetic denervation for refractory ventricular arrhythmias. J Am Coll Cardiol 2017; 69: 3070-80.","DOI":"10.1016\/j.jacc.2017.04.035"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Do DH, Bradfield J, Ajijola OA, <i>et al<\/i>. Thoracic epidural anesthesia can be effective for the short-term management of ventricular tachycardia storm. J Am Heart Assoc 2017; 6: e007080.","DOI":"10.1161\/JAHA.117.007080"},{"key":"28","unstructured":"28. S\u00e1nchez-\u00c1lvarez C, Gonz\u00e1lez-V\u00e9lez M, Stilp E, <i>et al<\/i>. Renal sympathetic denervation in the treatment of resistant hypertension. Yale J Biol Med 2014; 87: 527-35."},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Donazzan L, Mahfoud F, Ewen S, <i>et al<\/i>. Effects of catheter-based renal denervation on cardiac sympathetic activity and innervation in patients with resistant hypertension. Clin Res Cardiol 2016; 105: 364-71.","DOI":"10.1007\/s00392-015-0930-4"},{"key":"30","doi-asserted-by":"publisher","unstructured":"30. Bradfield JS, Hayase J, Liu K. Renal denervation as adjunctive therapy to cardiac sympathetic denervation for ablation refractory ventricular tachycardia. Heart Rhythm 2020; 17: 220-7.","DOI":"10.1016\/j.hrthm.2019.09.016"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Armaganijan LV, Staico R, Moreira DA, <i>et al<\/i>. 6-month outcomes in patients with implantable cardioverter-defibrillators undergoing renal sympathetic denervation for the treatment of refractory ventricular arrhythmias. JACC Cardiovasc Interv 2015; 8: 984-90.","DOI":"10.1016\/j.jcin.2015.03.012"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Aksu T, Guler E. Percutaneous renal sympathetic denervation in catecholaminergic polymorphic ventricular tachycardia. J Arrhythm 2017; 33: 245.","DOI":"10.1016\/j.joa.2016.12.004"},{"key":"33","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1093\/europace\/euz191","volume":"21","year":"2019","unstructured":"33. Mingyang X, Weijie C, Yuehui Y. Congenital long QT syndrome treated by renal sympathetic denervation. Europace 2019; 21: 1741.","journal-title":"Europace","ISSN":"http:\/\/id.crossref.org\/issn\/1099-5129","issn-type":"print"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Huang B, Zhou X, Wang S, <i>et al<\/i>. Renal sympathetic denervation: A potential therapeutic approach for long QT syndrome. Int J Cardiol 2015; 197: 206-7.","DOI":"10.1016\/j.ijcard.2015.06.080"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Wang S, Zhou X, Huang B, <i>et al<\/i>. Noninvasive low-frequency electromagnetic stimulation of the left stellate ganglion reduces myocardial infarction-induced ventricular arrhythmia. Sci Rep 2016; 6: 30783.","DOI":"10.1038\/srep30783"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Hoeker GS, Hanafy MA, Oster RA, <i>et al<\/i>. Reduced arrhythmia inducibility with calcium\/calmodulin-dependent protein kinase II inhibition in heart failure rabbits. J Cardiovasc Pharmacol 2016; 67: 260-5.","DOI":"10.1097\/FJC.0000000000000343"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Terentyev D, Rees CM, Li W, <i>et al<\/i>. Hyperphosphorylation of RyRs underlies triggered activity in transgenic rabbit model of LQT2 syndrome. Circ Res 2014; 115: 919-28.","DOI":"10.1161\/CIRCRESAHA.115.305146"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Tsuji Y, Hojo M, Voigt N, <i>et al<\/i>. Ca (2+) -related signaling and protein phosphorylation abnormalities play central roles in a new experimental model of electrical storm. Circulation 2011; 123: 2192-203.","DOI":"10.1161\/CIRCULATIONAHA.110.016683"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Liu N, Ruan Y, Denegri M, <i>et al<\/i>. Calmodulin kinase II inhibition prevents arrhythmias in RyR2 (R4496C+\/-) mice with catecholaminergic polymorphic ventricular tachycardia. J Mol Cell Cardiol 2011; 50: 214-22.","DOI":"10.1016\/j.yjmcc.2010.10.001"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Anderson ME, Brown JH, Bers DM. CaMKII in myocardial hypertrophy and heart failure. J Mol Cell Cardiol 2011; 51: 468-73.","DOI":"10.1016\/j.yjmcc.2011.01.012"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Heijman J, Voigt N, Nattel S, <i>et al<\/i>. Calcium handling and atrial fibrillation. Wien Med Wochenschr 2012; 162: 287-91.","DOI":"10.1007\/s10354-012-0109-9"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Li N, Wang T, Wang W, <i>et al<\/i>. Inhibition of CaMKII phosphorylation of RyR2 prevents induction of atrial fibrillation in FKBP12.6 knockout mice. Circ Res 2012; 110: 465-70.","DOI":"10.1161\/CIRCRESAHA.111.253229"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Sossalla S, Fluschnik N, Schotola H, <i>et al<\/i>. inhibition of elevated Ca2+\/calmodulin-dependent protein kinase II improves contractility in human failing myocardium. Circ Res 2010; 107: 1150-61.","DOI":"10.1161\/CIRCRESAHA.110.220418"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/62\/6\/62_21-662\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,4]],"date-time":"2021-12-04T03:44:46Z","timestamp":1638589486000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/62\/6\/62_21-662\/_article"}},"subtitle":["Mechanisms and Prospective Therapies"],"short-title":[],"issued":{"date-parts":[[2021,11,29]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.21-662","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,29]]},"article-number":"21-662"}}